{"id":"W4416187331","doi":"10.1080/14796694.2025.2577633","title":"Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Bayer","keywords":"Biochemical recurrence; Prostate cancer; Clinical endpoint; Prostatectomy; Prostate-specific antigen; Placebo; Radiation therapy; Glutamate carboxypeptidase II; Adjuvant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008406165,0.0003346947,0.000734694,0.0002613602,0.0001047203,0.00039625,0.0004749496,0.000368372,0.004054115],"category_scores_gemma":[0.0007736086,0.0001453943,0.0008614246,0.0003004227,0.0002646231,0.0002695313,0.0003388517,0.0009436166,0.000529428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002631113,"about_ca_system_score_gemma":0.000703057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005086006,"about_ca_topic_score_gemma":0.002869743,"domain_scores_codex":[0.9997124,0.0001627754,0.00002367217,0.00003067689,0.00003917962,0.00003118528],"domain_scores_gemma":[0.999595,0.0001022538,0.0001153123,0.00003773768,0.00003458284,0.0001151584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6721299,0.01840151,0.01391374,0.003217966,0.002634461,0.0002755796,0.0001595616,0.002531625,0.02345141,0.00093939,0.004848382,0.2574965],"study_design_scores_gemma":[0.4901773,0.4507636,0.03691964,0.0002298222,0.001520998,0.0004743818,0.00009849732,0.001310615,0.003453523,0.0005368073,0.01447713,0.00003773122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886785,0.003884887,0.0003056822,0.0002368658,0.0001162848,0.001304665,0.001418248,0.00006775854,0.003987021],"genre_scores_gemma":[0.9898168,0.002765516,0.001223792,0.0004895917,0.0001288326,0.001167178,0.001962322,0.000007995603,0.002437988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004054115,"threshold_uncertainty_score":0.01356244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01653389836474592,"score_gpt":0.3473627806221141,"score_spread":0.3308288822573682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}